A detailed history of Fmr LLC transactions in Argenx Se stock. As of the latest transaction made, Fmr LLC holds 3,527,986 shares of ARGX stock, worth $1.9 Billion. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,527,986
Previous 3,270,022 7.89%
Holding current value
$1.9 Billion
Previous $1.29 Billion 17.84%
% of portfolio
0.1%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$356.01 - $451.55 $91.8 Million - $116 Million
257,964 Added 7.89%
3,527,986 $1.52 Billion
Q1 2024

May 13, 2024

SELL
$356.95 - $413.29 $194 Million - $224 Million
-542,350 Reduced 14.23%
3,270,022 $1.29 Billion
Q4 2023

Feb 13, 2024

SELL
$338.91 - $506.01 $391 Million - $583 Million
-1,152,601 Reduced 23.21%
3,812,372 $1.45 Billion
Q3 2023

Nov 13, 2023

SELL
$369.35 - $548.43 $33.5 Million - $49.8 Million
-90,770 Reduced 1.8%
4,964,973 $2.44 Billion
Q2 2023

Aug 11, 2023

SELL
$360.14 - $422.58 $64 Million - $75.1 Million
-177,755 Reduced 3.4%
5,055,743 $1.97 Billion
Q1 2023

May 11, 2023

BUY
$334.23 - $403.65 $8.13 Million - $9.82 Million
24,329 Added 0.47%
5,233,498 $1.95 Billion
Q4 2022

Feb 13, 2023

BUY
$342.17 - $402.31 $8.02 Million - $9.43 Million
23,437 Added 0.45%
5,209,169 $1.97 Billion
Q3 2022

Nov 10, 2022

BUY
$343.2 - $395.75 $72.5 Million - $83.7 Million
211,389 Added 4.25%
5,185,732 $1.83 Billion
Q2 2022

Aug 12, 2022

BUY
$269.58 - $378.88 $79.3 Million - $111 Million
294,228 Added 6.29%
4,974,343 $1.88 Billion
Q1 2022

May 13, 2022

BUY
$254.45 - $351.06 $23.8 Million - $32.9 Million
93,716 Added 2.04%
4,680,115 $1.48 Billion
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $34.3 Million - $44.5 Million
125,986 Added 2.82%
4,586,399 $1.61 Billion
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $59.2 Million - $70.4 Million
-200,749 Reduced 4.31%
4,460,413 $1.35 Billion
Q2 2021

Aug 13, 2021

BUY
$257.11 - $319.92 $1.2 Billion - $1.49 Billion
4,661,162 New
4,661,162 $1.4 Billion

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $29.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.